DeutschNewstral
Article
Star Tribune on 2023-01-18 22:54
UnitedHealth's Optum gets FDA warning letter over 'serious deficiencies' at infusion facility
Related news
- Optum joins FDA, manufacturer in recalling infusion pumps that killed one patientStar Tribune
UnitedHealth's Optum Profits Overcome Obamacare ExitForbes- UnitedHealth's Optum Sales Hit $100B For First TimeForbes
- MUnitedHealth's Optum to acquire Diplomat Pharmacy for $4 a share in cashmarketwatch.com
- FDA slaps Class 1 recall label on Minnesota-made syringe infusion pumpStar Tribune
FDA points to deficiencies in Vanda's latest drug applicationbizjournals.com
No deficiencies found at Chandler facility with 16 virus deathssantansun.com- UnitedHealth's Optum closes $12.8B deal for Catamaranbizjournals.com
- UnitedHealth's Optum is digging into blockchain's potentialbizjournals.com
FDA Approves New Drug For Treating Pill DeficienciesThe Onion- UnitedHealth's Optum taps partners in blockchain pushbizjournals.com
- Ex-GlaxoSmithKline CEO to lead UnitedHealth's Optumbizjournals.com
- FDA deal sharply limits Medtronic infusion pump manufacturing, salesStar Tribune
Blue Bell recall 2015: FDA unaware listeria found in ice cream facility in 2013al.com- UnitedHealth's Optum Launches $250M Fund To Invest In Start-UpsForbes
- UnitedHealth's Optum part of $2.2B deal for doctor-staffing companybizjournals.com
- UnitedHealth's Optum Now In Half Of 75 Targeted Provider MarketsForbes
- UnitedHealth's Optum Boosts Profits As ACA Demands Population HealthForbes
- UnitedHealth's Optum To Buy Surgery Center Business For $2.3 BillionForbes
- UnitedHealth's Optum To Buy DaVita's Doctor Clinics For $4.9 BillionForbes